Models of the Cytochromes
J. Am. Chem. Soc., Vol. 119, No. 40, 1997 9439
each other. Proteins of the latter group have been identified
largely on the basis of spectroscopic data for the oxidized
(Fe(III)) forms, and include the b hemes of mitochondrial
complex III, also known as cytochrome bc1,17 the similar b
hemes of cytochrome b6f of chloroplasts, one of the c-type
hemes of cytochrome c3,13 and the c-type heme of cytochrome
c′′ of Methylophilus methylotrophus.18
During the time over which our studies of bis(hindered
imidazole) and -(pyridine) complexes of Fe(III) porphyrinates
were being carried out and the above-described hypothesis was
developed, we had assumed that for the closed subshell
configuration of low-spin d6 Fe(II) porphyrinates, planar axial
ligands would prefer to align themselves in mutually perpen-
dicular planes, to maximize the π-bonding interactions between
the filled dπ orbitals of Fe(II) and the π* orbitals of the ligands.
However, the investigations reported herein, which involve
structural, spectroscopic, and thermodynamic measurements of
bis(pyridine) complexes of (tetramesitylporphyrinato)iron(II),
clearly show that low-spin Fe(II) porphyrinates strongly pre-
fer to have planar axial ligands oriented parallel to each other,
and that π-bonding interactions between Fe(II) and the axial
ligands are minimal. Herein we report the structures of three
complexes, [Fe(TMP)(4-CNPy)2], [Fe(TMP)(3-CNPy)2], and
[Fe(TMP)(4-MePy)2], and the Mo¨ssbauer parameters of a series
of FeII(TMP) complexes with pyridines of widely varying
basicities, where, in all cases, the analogous FeIII(TMP) deriva-
tive is known to have mutually perpendicular axial ligands.21,22
The solid state properties of these ferrocytochrome models will
then be compared to the thermodynamic properties of the same
complexes in homogeneous solution (reduction potentials of the
FeIII/FeII couples and the equilibrium constants for binding the
axial ligands to Fe(II) TMP at ambient temperatures).26 Possible
reasons for and consequences of the lack of sensitivity of low-
spin Fe(II) porphyrinate bis-ligand complexes to the σ-donor
and π-donor/acceptor properties of the axial ligands will be
evaluated.
Based on structural and spectroscopic investigations of the
bis(2-methylimidazole) complex of (tetraphenylporphyrinato)-
iron(III), [TPPFe(2-MeHIm)2]+,19,20 we concluded some time
ago that for low-spin d5 ferriheme centers, parallel orientation
of axial ligands is energetically favored, and that either bulky
axial ligands, such as 2-methylimidazole (or, as we later found,
the combination of tetrakis(2,6-disubstituted phenyl)porphyri-
nates together with pyridines21,22 or bulky imidazoles23 ), are
required to force the perpendicular relative orientation of planar
axial ligands in Fe(III) porphyrinates. We also proposed that
the reduction potentials of bis-histidine-ligated cytochromes
might in part be determined by the orientation of the axial ligand
planes, with perpendicular orientation creating the more positive
reduction potential.16 This appeared to be consistent with the
observation that the membrane-bound bis-histidine-coordinated
b cytochromes of the bc1 and b6f complexes, whose single-
feature EPR spectra suggest that the imidazole planes are
perpendicularly oriented,17 tend to have more positive reduction
potentials17b,24 than those for which the EPR signals are rhom-
bic25 and the structures are known or believed to have parallel-
oriented imidazole planes.9 Inherent in this hypothesis is the
belief that no change would take place in histidine imidazole
plane orientation when electron transfer occurred, and hence
both Fe(III) and Fe(II) forms of each limiting type of cytochrome
would have the same ligand orientations. This is known to be
the case for some of the small, water-soluble cytochromes such
Experimental Section
General Information. Reactions were performed with solvents
distilled under argon prior to use. THF and benzene were distilled
from sodium benzophenone ketyl. Dichloromethane, chloroform, and
hexane were distilled from CaH2. 4-Cyanopyridine was recrystallized
from CH2Cl2. Other imidazole and pyridine ligands were obtained from
Aldrich and used without further purification. Tetramesitylporphyrin
was prepared by slight modification of the procedures by Lindsey et
al.,27 and as described previously.21 The [Fe(TMP)(OH)] was prepared
by shaking a CH2Cl2 solution of [Fe(TMP)Cl] with a 2 M solution of
KOH. The reduced iron complex, [Fe(TMP)], was prepared by
reducing a benzene solution of [Fe(TMP)(OH)] with ethanethiol or a
chloroform solution with Zn(Hg). Solid [Fe(TMP)] precipitated from
the benzene solution. UV-vis (benzene): Split soret 419.0, 430.2; R
and â bands 527.5, 562.9 nm. This [Fe(TMP)] was immediately used
for synthesis of the bis-pyridine complexes.
9
as cytochrome b5 and c,10 but has not yet been elucidated for
the membrane-bound b cytochromes.
(15) (a) Xia, Z.-X.; Shamala, N.; Bethge, P. H.; Lim, L. W.; Bellamy,
H. D.; Xuong, N. H.; Lederer, F.; Mathews, F. S. Proc. Natl. Acad. Sci.
U.S.A. 1987, 84, 2629. (b) Dubois, J.; Chapman, S. K.; Mathews, F. S.;
Reid, G. A.; Lederer, F. Biochemistry 1990, 29, 6393.
(16) Iwata, S.; Ostermeier, C.; Ludwig, B.; Michel, H. Nature 1995, 376,
660.
(17) (a) Salerno, J. C. J. Biol. Chem. 1984, 259, 2331. (b) Tsai, A.;
Palmer, G. Biochim. Biophys. Acta 1982, 681, 484. (c) Tsai, A.-H.; Palmer,
G. Biochim. Biophys. Acta 1983, 722, 349.
(18) (a) Berry, M. J.; George, S. J.; Thomson, A. J.; Santos, H.; Turner,
D. L. Biochem. J. 1990, 270, 413. (b) Costa, H. S.; Santos, H.; Turner, D.
L.; Xavier, A. V. Eur. J. Biochem. 1992, 208, 427. (c) Costa, H. S.; Santos,
H.; Turner, D. L. Eur. J. Biochem. 1993, 215, 817.
Mo¨ssbauer samples were prepared as mulls in Apiezon L grease.
Mo¨ssbauer measurements were made at 4.2 and/or 120 K on a constant-
acceleration spectrometer. The spectra were fitted with two Lorentzians
of equal area. Isomer shifts are quoted relative to metallic iron at room
temperature. UV-visible spectra were recorded on a Perkin-Elmer
Lambda 4C spectrophotometer.
Synthesis of [Fe(TMP)(4-CNPy)2]. A chloroform solution (15 mL)
of [Fe(TMP)] prepared by reduction of [Fe(TMP)(OH)] (130 mg, 0.150
mmol) with Zn(Hg) was transferred by cannula filtration into a Schlenk
flask containing the 4-cyanopyridine ligand (300 mg, 2.88 mmol). The
reaction mixture was shaken for a minute, and then layered with hexane
for crystallization. X-ray quality crystals formed after 5 days. UV-
vis (CHCl3) λmax (log ꢀ): 421.0 (5.09), 527.2 (4.16), 558.0 (4.03) nm.
Synthesis of [Fe(TMP)(3-CNPy)2]. A chloroform solution (15 mL)
of [Fe(TMP)] prepared by reduction of [Fe(TMP)(OH)] (80 mg, 0.080
mmol) with Zn(Hg) was cannula-filtered into a Schlenk flask containing
the 3-cyanopyridine ligand (250 mg, 2.40 mmol). The reaction mixture
(19) Walker, F. A.; Huynh, B. H.; Scheidt, W. R.; Osvath, S. R. J. Am.
Chem. Soc. 1986, 108, 5288.
(20) Abbreviations used: Axial ligands: 2-MeHIm, 2-methylimidazole;
1,2-Me2Im, 1,2-dimethylimidazole; 1-MeIm, 1-methylimidazole; 1-VinIm,
1-vinylimidazole; 1-BzylIm, 1-benzylimidazole; 4-CNPy, 4-cyanopyridine;
3-CNPy, 3-cyanopyridine; 3-ClPy, 3-chloropyridine; 4-MePy, 4-methylpy-
ridine; Py, pyridine; 4-NMe2Py, 4-(dimethylamino)pyridine; PMe3, tri-
methylphosphine; DMF, dimethylformamide. Porphyrins: TMP, tetramesi-
tylporphyrin; TPP, tetraphenylporphyrin; (2,6-Cl2)4TPP, tetrakis(2,6-dichlo-
rophenyl)porphyrin; (2,6-Br2)4TPP, tetrakis(2,6-dibromophenyl)porphy-
rin; (2,6-F2)4TPP, tetrakis(2,6-difluorophenyl)porphyrin; (2,6-(OMe)2)4TPP,
tetrakis(2,6-dimethoxyphenyl)porphyrin; OEP, octaethylporphyrin. Other:
Np, porphinato nitrogen; MM2, molecular mechanics program; â2II, equi-
librium constant for binding two axial ligands to iron(II) porphyrinates;
â2III, equilibrium constant for bidning two axial ligands to iron(III)
porphyrinates.
(21) Safo, M. K.; Gupta, G. P.; Walker, F. A.; Scheidt, W. R. J. Am.
Chem. Soc. 1991, 113, 5497.
(22) Safo, M. K.; Gupta, G. P.; Watson, C. T.; Simonis, U.; Walker, F.
A.; Scheidt, W. R. J. Am. Chem. Soc. 1992, 114, 7066.
(23) Munro, O. Q.; Marques, H. M.; Debrunner, P. G.; Mohanrao, K.;
Scheidt, W. R. J. Am. Chem. Soc. 1995, 117, 935.
(24) von Jagow, G.; Engel, W. D. Angew. Chem., Int. Ed. Engl. 1980,
19, 659.
(25) Rivera, Barillas-Mury, C.; Christensen, K. A.; Little, J. W.; Wells,
M. A.; Walker, F. A. Biochemistry 1992, 31, 12233 and references therein.
(26) Nesset, M. J. M.; Shokhirev, N. V.; Enemark, P. D.; Jacobson, S.
E.; Walker, F. A. Inorg. Chem. 1996, 35, 5188.
(27) Watner, R. W.; Lawrence, D. S.; Lindsey, J. S. Tetrahedron Lett.
1987, 28, 3069. Lindsey, J. S.; Wagner, R. W. J. Org. Chem. 1988, 54,
828.